Your browser doesn't support javascript.
loading
Loss of primary cilia promotes inflammation and carcinogenesis.
Paul, Conception; Tang, Ruizhi; Longobardi, Ciro; Lattanzio, Rossano; Eguether, Thibaut; Turali, Hulya; Bremond, Julie; Maurizy, Chloé; Gabola, Monica; Poupeau, Sophie; Turtoi, Andrei; Denicolai, Emilie; Cufaro, Maria Concetta; Svrcek, Magali; Seksik, Philippe; Castronovo, Vincent; Delvenne, Philippe; de Laurenzi, Vincenzo; Da Costa, Quentin; Bertucci, François; Lemmers, Bénédicte; Pieragostino, Damiana; Mamessier, Emilie; Janke, Carsten; Pinet, Valérie; Hahne, Michael.
Affiliation
  • Paul C; Institut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Label "Equipe FRM", Montpellier, France.
  • Tang R; Institut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Label "Equipe FRM", Montpellier, France.
  • Longobardi C; Institut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Label "Equipe FRM", Montpellier, France.
  • Lattanzio R; Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Eguether T; Oncode Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Turali H; Department of Innovative Technologies in Medicine & Dentistry, Center for Advanced Studies and Technology (CAST), 'G. d'Annunzio' University of Chieti-Pescara, Chieti, Italy.
  • Bremond J; Centre de Recherche Saint Antoine, Sorbonne Université, INSERM, APHP, Paris, France.
  • Maurizy C; Institut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Label "Equipe FRM", Montpellier, France.
  • Gabola M; Institut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Label "Equipe FRM", Montpellier, France.
  • Poupeau S; Institut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Label "Equipe FRM", Montpellier, France.
  • Turtoi A; Institut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Label "Equipe FRM", Montpellier, France.
  • Denicolai E; Institut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Label "Equipe FRM", Montpellier, France.
  • Cufaro MC; Tumor Microenvironment and Resistance to Treatment Laboratory, Institut de Recherche en Cancérologie de Montpellier, Montpellier, France.
  • Svrcek M; Cancer Research Center of Marseille (CRCM), Laboratory of Predictive Oncology, Inserm U1068 - CNRS UMR7258 - University of Aix-Marseille UM105 - Paoli Calmettes Institute (IPC), Label "Ligue contre le cancer", Marseille, France.
  • Seksik P; Department of Innovative Technologies in Medicine & Dentistry, Center for Advanced Studies and Technology (CAST), 'G. d'Annunzio' University of Chieti-Pescara, Chieti, Italy.
  • Castronovo V; Department of Pathology, AP-HP, Hôpital Saint-Antoine, Sorbonne Université, Paris, France.
  • Delvenne P; Centre de Recherche Saint Antoine, Sorbonne Université, INSERM, APHP, Paris, France.
  • de Laurenzi V; Metastasis Research Laboratory, GIGA Cancer, University of Liège, Liège, Belgium.
  • Da Costa Q; Cancer Research Center of Marseille (CRCM), Laboratory of Predictive Oncology, Inserm U1068 - CNRS UMR7258 - University of Aix-Marseille UM105 - Paoli Calmettes Institute (IPC), Label "Ligue contre le cancer", Marseille, France.
  • Bertucci F; Department of Pathology, University Hospital (CHU), University of Liège, Liège, Belgium.
  • Lemmers B; Department of Innovative Technologies in Medicine & Dentistry, Center for Advanced Studies and Technology (CAST), 'G. d'Annunzio' University of Chieti-Pescara, Chieti, Italy.
  • Pieragostino D; Cancer Research Center of Marseille (CRCM), Laboratory of Predictive Oncology, Inserm U1068 - CNRS UMR7258 - University of Aix-Marseille UM105 - Paoli Calmettes Institute (IPC), Label "Ligue contre le cancer", Marseille, France.
  • Mamessier E; Cancer Research Center of Marseille (CRCM), Laboratory of Predictive Oncology, Inserm U1068 - CNRS UMR7258 - University of Aix-Marseille UM105 - Paoli Calmettes Institute (IPC), Label "Ligue contre le cancer", Marseille, France.
  • Janke C; Institut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Label "Equipe FRM", Montpellier, France.
  • Pinet V; Department of Innovative Technologies in Medicine & Dentistry, Center for Advanced Studies and Technology (CAST), 'G. d'Annunzio' University of Chieti-Pescara, Chieti, Italy.
  • Hahne M; Cancer Research Center of Marseille (CRCM), Laboratory of Predictive Oncology, Inserm U1068 - CNRS UMR7258 - University of Aix-Marseille UM105 - Paoli Calmettes Institute (IPC), Label "Ligue contre le cancer", Marseille, France.
EMBO Rep ; 23(12): e55687, 2022 12 06.
Article in En | MEDLINE | ID: mdl-36281991
ABSTRACT
Primary cilia (PC) are important signaling hubs, and we here explored their role in colonic pathology. In the colon, PC are mostly present on fibroblasts, and exposure of mice to either chemically induced colitis-associated colon carcinogenesis (CAC) or dextran sodium sulfate (DSS)-induced acute colitis decreases PC numbers. We generated conditional knockout mice with reduced numbers of PC on colonic fibroblasts. These mice show increased susceptibility to CAC, as well as DSS-induced colitis. Secretome and immunohistochemical analyses of DSS-treated mice display an elevated production of the proinflammatory cytokine IL-6 in PC-deficient colons. An inflammatory environment diminishes PC presence in primary fibroblast cultures, which is triggered by IL-6 as identified by RNA-seq analysis together with blocking experiments. These findings suggest an activation loop between IL-6 production and PC loss. An analysis of PC presence on biopsies of patients with ulcerative colitis or colorectal cancer (CRC) reveals decreased numbers of PC on colonic fibroblasts in pathological compared with surrounding normal tissue. Taken together, we provide evidence that a decrease in colonic PC numbers promotes colitis and CRC.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interleukin-6 / Cilia Type of study: Prognostic_studies Limits: Animals Language: En Journal: EMBO Rep Journal subject: BIOLOGIA MOLECULAR Year: 2022 Type: Article Affiliation country: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interleukin-6 / Cilia Type of study: Prognostic_studies Limits: Animals Language: En Journal: EMBO Rep Journal subject: BIOLOGIA MOLECULAR Year: 2022 Type: Article Affiliation country: France